Stock listing
Stuttgart:NOTA Novartis AG Aktie
German listing (Stuttgart) of Novartis AG · home listing SIX Swiss:NOVN
Follow Novartis AG into a list and get an email when it puts out news.
Share price · SWB:NOTA
€144.00 EUR -2.00 (-1.4%)
Close on Nov 5, 2026
- Day range
- €143.00 – €147.00 EURNov 5, 2026
- Volume
- 70 sharesNov 5, 2026
- 52-week range
- €107.00 – €147.00 EURLowest and highest trades, Nov 6, 2025 – Nov 5, 2026
- Traded on an average day
- €3,358 EURMedian day 0 shares · 46 days with no trades · last 3 months, Aug 5, 2026 – Nov 5, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:NOVN · Home | 134.26 CHF | -1.50 (-1.1%) | 374,101 | 134.98 | 135.28 | 134.14 | 135.76 | Delayed 15+ min · 12:44 PM GMT+1, Nov 17, 2026 |
| NYSE:NVS | $160.20 USD | -0.30 (-0.2%) | 1,630,384 | $162.36 | $163.28 | $159.94 | $160.50 | Close on Nov 16, 2026 |
| OTC:NVSEF | $159.26 USD | -2.855 (-1.8%) | 403 | $165.52 | $165.52 | $159.26 | $162.12 | Close on Nov 16, 2026 |
| Frankfurt:NOTA | €145.00 EUR | +2.00 (+1.4%) | — | €145.00 | €145.00 | €145.00 | €143.00 | Close on Nov 16, 2026 |
| B3:N1VS34 | 93.42 BRL | +2.34 (+2.6%) | 49 | 92.85 | 93.69 | 91.08 | 91.08 | Close on Nov 16, 2026 |
| TSX:NVS | $32.32 CAD | +0.31 (+1.0%) | 421 | $32.55 | $32.55 | $32.32 | $32.01 | Close on Nov 16, 2026 |
| LSE:0K9E | $161.15 USD | +0.85 (+0.5%) | 993 | $160.99 | $163.99 | $160.99 | $160.30 | Close on Nov 16, 2026 |
| Stuttgart:NOT | €145.60 EUR | +0.12 (+0.1%) | — | €145.28 | €148.02 | €145.28 | €145.48 | Close on Nov 16, 2026 |
| Munich:NOT | €145.90 EUR | +0.96 (+0.7%) | — | €145.94 | €145.94 | €145.90 | €144.94 | Close on Nov 16, 2026 |
| Dusseldorf:NOT | €145.52 EUR | +0.04 (0.0%) | — | €145.52 | €145.52 | €145.52 | €145.48 | Close on Nov 16, 2026 |
| Stuttgart:NOTA | €144.00 EUR | -2.00 (-1.4%) | 70 | €146.00 | €147.00 | €143.00 | €146.00 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 5, 2026 – Nov 5, 2026 · SWB:NOTA · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €144.00 | -2.00 | -1.4% | €146.00 | €147.00 | €143.00 | 70 | |
| €146.00 | +3.00 | +2.1% | €142.00 | €146.00 | €141.00 | 81 | |
| €143.00 | -1.00 | -0.7% | €144.00 | €145.00 | €142.00 | 0 | |
| €144.00 | +1.00 | +0.7% | €142.00 | €144.00 | €142.00 | 0 | |
| €143.00 | -1.00 | -0.7% | €144.00 | €146.00 | €143.00 | 0 | |
| €144.00 | +5.00 | +3.6% | €139.00 | €144.00 | €139.00 | 0 | |
| €139.00 | -1.00 | -0.7% | €140.00 | €141.00 | €138.00 | 1 | |
| €140.00 | +3.00 | +2.2% | €138.00 | €140.00 | €137.00 | 0 | |
| €137.00 | +3.00 | +2.2% | €134.00 | €138.00 | €134.00 | 0 | |
| €134.00 | -5.00 | -3.6% | €139.00 | €139.00 | €133.00 | 0 | |
| €139.00 | +2.00 | +1.5% | €136.00 | €140.00 | €136.00 | 300 | |
| €137.00 | +1.00 | +0.7% | €136.00 | €137.00 | €136.00 | 35 | |
| €136.00 | +3.00 | +2.3% | €133.00 | €136.00 | €133.00 | 35 | |
| €133.00 | 0.00 | 0.0% | €134.00 | €134.00 | €133.00 | 0 | |
| €133.00 | -1.00 | -0.7% | €133.00 | €134.00 | €133.00 | 0 | |
| €134.00 | +3.00 | +2.3% | €130.00 | €135.00 | €130.00 | 397 | |
| €131.00 | +4.00 | +3.1% | €127.00 | €131.00 | €127.00 | 0 | |
| €127.00 | -2.00 | -1.6% | €128.00 | €129.00 | €127.00 | 0 | |
| €129.00 | +1.00 | +0.8% | €128.00 | €129.00 | €127.00 | 0 | |
| €128.00 | +1.00 | +0.8% | €127.00 | €128.00 | €127.00 | 0 | |
| €127.00 | 0.00 | 0.0% | €127.00 | €127.00 | €125.00 | 0 | |
| €127.00 | +3.00 | +2.4% | €125.00 | €129.00 | €124.00 | 26 | |
| €124.00 | -1.00 | -0.8% | €126.00 | €127.00 | €124.00 | 100 | |
| €125.00 | 0.00 | 0.0% | €126.00 | €127.00 | €124.00 | 100 | |
| €125.00 | 0.00 | 0.0% | €125.00 | €126.00 | €124.00 | 0 | |
| €125.00 | -1.00 | -0.8% | €125.00 | €126.00 | €124.00 | 0 | |
| €126.00 | -2.00 | -1.6% | €127.00 | €129.00 | €126.00 | 0 | |
| €128.00 | -1.00 | -0.8% | €129.00 | €129.00 | €127.00 | 110 | |
| €129.00 | +2.00 | +1.6% | €127.00 | €129.00 | €127.00 | 24 | |
| €127.00 | +1.00 | +0.8% | €125.00 | €127.00 | €124.00 | 0 | |
| €126.00 | +1.00 | +0.8% | €125.00 | €127.00 | €125.00 | 0 | |
| €125.00 | +2.00 | +1.6% | €123.00 | €126.00 | €123.00 | 0 | |
| €123.00 | 0.00 | 0.0% | €121.00 | €124.00 | €121.00 | 35 | |
| €123.00 | +1.00 | +0.8% | €121.00 | €123.00 | €121.00 | 0 | |
| €122.00 | 0.00 | 0.0% | €122.00 | €123.00 | €121.00 | 0 | |
| €122.00 | +2.00 | +1.7% | €120.00 | €122.00 | €120.00 | 0 | |
| €120.00 | 0.00 | 0.0% | €119.00 | €123.00 | €119.00 | 10 | |
| €120.00 | 0.00 | 0.0% | €120.00 | €121.00 | €119.00 | 10 | |
| €120.00 | +2.00 | +1.7% | €118.00 | €122.00 | €118.00 | 170 | |
| €118.00 | 0.00 | 0.0% | €119.00 | €119.00 | €118.00 | 50 | |
| €118.00 | 0.00 | 0.0% | €120.00 | €120.00 | €117.00 | 110 | |
| €118.00 | -13.00 | -9.9% | €117.00 | €119.00 | €117.00 | 0 | |
| €131.00 | -2.00 | -1.5% | €131.00 | €131.00 | €131.00 | 0 | |
| €133.00 | -4.00 | -2.9% | €132.00 | €135.00 | €132.00 | 0 | |
| €137.00 | -3.00 | -2.1% | €140.00 | €140.00 | €137.00 | 0 | |
| €140.00 | 0.00 | 0.0% | €140.00 | €141.00 | €139.00 | 0 | |
| €140.00 | +1.00 | +0.7% | €138.00 | €140.00 | €137.00 | 0 | |
| €139.00 | +8.00 | +6.1% | €130.00 | €140.00 | €130.00 | 0 | |
| €131.00 | -1.00 | -0.8% | €132.00 | €132.00 | €130.00 | 0 | |
| €132.00 | 0.00 | 0.0% | €132.00 | €133.00 | €131.00 | 0 | |
| €132.00 | -3.00 | -2.2% | €135.00 | €135.00 | €132.00 | 0 | |
| €135.00 | -2.00 | -1.5% | €136.00 | €137.00 | €134.00 | 0 | |
| €137.00 | +2.00 | +1.5% | €135.00 | €137.00 | €135.00 | 0 | |
| €135.00 | -1.00 | -0.7% | €136.00 | €136.00 | €134.00 | 0 | |
| €136.00 | +3.00 | +2.3% | €133.00 | €136.00 | €133.00 | 0 | |
| €133.00 | -4.00 | -2.9% | €137.00 | €137.00 | €133.00 | 0 | |
| €137.00 | +4.00 | +3.0% | €133.00 | €137.00 | €133.00 | 0 | |
| €133.00 | +2.00 | +1.5% | €131.00 | €133.00 | €131.00 | 4 | |
| €131.00 | +1.00 | +0.8% | €130.00 | €131.00 | €130.00 | 0 | |
| €130.00 | -1.00 | -0.8% | €130.00 | €130.00 | €128.00 | 4 | |
| €131.00 | -1.00 | -0.8% | €132.00 | €132.00 | €131.00 | 0 | |
| €132.00 | -1.00 | -0.8% | €133.00 | €133.00 | €131.00 | 0 | |
| €133.00 | -2.00 | -1.5% | €135.00 | €136.00 | €133.00 | 0 | |
| €135.00 | 0.00 | 0.0% | €134.00 | €135.00 | €134.00 | 0 | |
| €135.00 | +2.00 | +1.5% | €133.00 | €136.00 | €133.00 | 45 | |
| €133.00 | 0.00 | 0.0% | €133.00 | €134.00 | €133.00 | 0 | |
| €133.00 | +1.00 | +0.8% | €132.00 | €134.00 | €132.00 | 0 |
- Ticker
- Stuttgart:NOTA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Nov 17, 2026
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
Latest earnings call · Oct 27, 2026
Novartis (SIX Swiss: NOVN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 27, 2026
Q3 2026 Earnings Presentation
Earnings · 91 slides
Calls
Replays
Novartis (SIX Swiss: NOVN) Q3 2026 Earnings Call
Tue, Oct 27, 2026 · 7:00 AM ET
Watch TranscriptNovartis (SIX Swiss: NOVN) Q2 2026 Earnings Call
Tue, Jul 21, 2026 · 8:00 AM ET
Watch TranscriptNovartis (SIX Swiss: NOVN) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
Oct 27, 2026
Closed €140.00 (+2.2%) on Oct 27, 2026
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
Oct 23, 2026
Closed €137.00 (+2.2%) on Oct 26, 2026
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
Oct 21, 2026
Closed €139.00 (+1.5%) on Oct 22, 2026
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
Oct 7, 2026
Closed €127.00 (0.0%) on Oct 8, 2026
CAS ประกาศความร่วมมือกับ Novartis เพื่อขับเคลื่อนระบบข้อมูลด้านปฏิกิริยาเคมีที่พร้อมรองรับ AI
Sep 29, 2026
Closed €128.00 (-0.8%) on Sep 29, 2026
Issued by another party
Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
Sep 18, 2026
Closed €123.00 (+0.8%) on Sep 21, 2026
Sironax Announces Option Exercise and Asset Purchase
Sep 16, 2026
Closed €120.00 (0.0%) on Sep 16, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 91 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 46 slides · Oct 23, 2026
Q2 2026 Earnings Presentation
Earnings · 87 slides · Jul 21, 2026
Q1 2026 Earnings Presentation
Earnings · 85 slides · Apr 28, 2026
Novartis AG on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 84 in the last 12 months · 117 in all · newest Nov 17, 2026 · oldest 2025
- Calls
- 26 calls with a replay · 26 with a transcript · latest Oct 27, 2026
- Decks
- 186 decks · latest Oct 27, 2026
Where Novartis AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:NOVN · Home listing | SIX Swiss | Switzerland | CHF |
| NYSE:NVS | NYSE | United States | USD |
| Xetra:NOT | Xetra | Germany | EUR |
| gettex:NOT | gettex | Germany | EUR |
| OTC:NVSEF | OTC | United States | USD |
| Tradegate:NOT | Tradegate | Germany | EUR |
| Milan:1NOVN | Milan | Italy | EUR |
| BCBA:NVS | BCBA | Argentina | ARS |
| LSIN:0QLR | LSIN | United Kingdom | CHF |
| gettex:NOTA | gettex | Germany | EUR |
| LS Exchange:904278 | LS Exchange | Germany | EUR |
| SIX Swiss:NOVNEE | SIX Swiss | Switzerland | CHF |
| BX Swiss:NOT | BX Swiss | Switzerland | CHF |
| Frankfurt:NOT | Frankfurt | Germany | EUR |
| Frankfurt:NOTA | Frankfurt | Germany | EUR |
| VIE:NOVN | Vienna | Austria | EUR |
| B3:N1VS34 | B3 | Brazil | BRL |
| Tradegate:NOTA | Tradegate | Germany | EUR |
| TSX:NVS | TSX | Canada | CAD |
| Lang & Schwarz:904278 | Lang & Schwarz | Germany | EUR |
| Aquis:NOVNZ | Aquis | United Kingdom | CHF |
| Cboe Canada:NOVN | Cboe Canada | Canada | CAD |
| LSE:0K9E | LSE | United Kingdom | USD |
| Cboe Canada:NVS | Cboe Canada | Canada | CAD |
| Stuttgart:NOT | Stuttgart | Germany | EUR |
| BCBA:NVSD | BCBA | Argentina | USD |
| Munich:NOT | Munich | Germany | EUR |
| LS Exchange:907122 | LS Exchange | Germany | EUR |
| BMV:NVSN | BMV | Mexico | MXN |
| BCBA:NVSC | BCBA | Argentina | USD |
| BMV:NOVNN | BMV | Mexico | MXN |
| Hamburg:NOT | Hamburg | Germany | EUR |
| BOATS:NVS | BOATS | United States | USD |
| Dusseldorf:NOT | Dusseldorf | Germany | EUR |
| BCBA:NVSB | BCBA | Argentina | ARS |
| Stuttgart:NOTA · This page | Stuttgart | Germany | EUR |
| Dusseldorf:NOTA | Dusseldorf | Germany | EUR |
| Hanover:NOT | Hanover | Germany | EUR |
| Frankfurt:NOT1 | Frankfurt | Germany | EUR |
| Turquoise:NOVNZ | Turquoise | United Kingdom | CHF |
| BIVA:NOVNN | BIVA | Mexico | MXN |
| Lang & Schwarz:907122 | Lang & Schwarz | Germany | EUR |
| Munich:NOTA | Munich | Germany | EUR |
| Frankfurt:NOT0 | Frankfurt | Germany | EUR |
| Hamburg:NOTA | Hamburg | Germany | EUR |
| BCBA:NVS.CI | BCBA | Argentina | ARS |
Log in to ask 6ix AI your own questions about Novartis AG.